Curium Plans to Significantly Expand Lutetium-177 Capacity and Pet Footprint With Agreement to Acquire Eczacibaşi-Monrol

The proposed acquisition of Eczacıbaşı-Monrol will: Build on existing partnership in Lu-177 creating a leading manufacturer of the isotopeAdd 12 PET sites to Curium's existing network in geographies where Curium is not

Related Keywords

Istanbul ,Turkey ,Bozlu ,Hatay ,United States ,Paris ,France General ,France ,Ben Valdimarsson ,Ross Bethell ,Aydin Kucuk ,Pierre Curie ,Bozlu Group ,Reputation Inc ,Head Of Global Communications ,Monrol Nuclear Product Co ,Healthcare Group ,Monrol Nuclear Product ,Western Europe ,Eastern Europe ,Chaitanya Tatineni ,Aydin Kucuk General Manager ,Emin Fad ,